X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (38) 38
humans (30) 30
oncology (29) 29
female (19) 19
male (17) 17
middle aged (17) 17
cancer (16) 16
adult (14) 14
lung neoplasms - drug therapy (14) 14
aged (12) 12
carcinoma, non-small-cell lung - drug therapy (12) 12
chemotherapy (12) 12
lung neoplasms - pathology (12) 12
mutation (11) 11
carcinoma, non-small-cell lung - pathology (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
patients (8) 8
research (8) 8
aged, 80 and over (7) 7
research report (7) 7
respiratory system (7) 7
care and treatment (6) 6
erlotinib (6) 6
gefitinib (6) 6
hematology, oncology and palliative medicine (6) 6
lung cancer (6) 6
lung cancer, non-small cell (6) 6
neoplasm staging (6) 6
therapy (6) 6
cisplatin (5) 5
disease-free survival (5) 5
genomes (5) 5
lung neoplasms - genetics (5) 5
resistance (5) 5
survival analysis (5) 5
adenocarcinoma (4) 4
antineoplastic agents - therapeutic use (4) 4
carboplatin (4) 4
carboplatin - administration & dosage (4) 4
carboplatin - adverse effects (4) 4
expression (4) 4
genomics (4) 4
metastasis (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
paclitaxel (4) 4
phase-iii trial (4) 4
research article (4) 4
retrospective studies (4) 4
treatment outcome (4) 4
adenocarcinoma - drug therapy (3) 3
adenocarcinoma - genetics (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
bevacizumab (3) 3
british columbia (3) 3
cancer therapies (3) 3
carcinoma, non-small-cell lung - genetics (3) 3
care (3) 3
clinical trials (3) 3
cohort studies (3) 3
disease progression (3) 3
docetaxel (3) 3
egfr (3) 3
gene expression profiling (3) 3
genetic aspects (3) 3
high-throughput nucleotide sequencing (3) 3
immunohistochemistry (3) 3
lung neoplasms - mortality (3) 3
medical prognosis (3) 3
medical treatment (3) 3
medicine (3) 3
metastases (3) 3
multicenter (3) 3
neoplasm metastasis (3) 3
neoplasm of the breast (3) 3
non-small cell lung cancer (3) 3
nsclc (3) 3
oncology, experimental (3) 3
pancreas (3) 3
pathway (3) 3
prognosis (3) 3
pulmonary/respiratory (3) 3
quinazolines - administration & dosage (3) 3
radiotherapy (3) 3
randomized-trial (3) 3
receptor, epidermal growth factor - genetics (3) 3
signatures (3) 3
squamous-cell carcinoma (3) 3
studies (3) 3
surgery (3) 3
survival (3) 3
trial (3) 3
tyrosine kinase inhibitors (3) 3
young adult (3) 3
adenocarcinoma - pathology (2) 2
adolescent (2) 2
afatinib (2) 2
age factors (2) 2
analysis (2) 2
animals (2) 2
antibodies, monoclonal - therapeutic use (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 577 - 589
Journal Article
Journal Article
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 08/2019, Volume 25, Issue 15, pp. 4674 - 4681
Purpose: Gene fusions involving neuregulin 1 (NRG1) have been noted in multiple cancer types and have potential therapeutic implications. Although varying... 
PATHWAYS | MUTATIONAL PROCESSES | SIGNATURES | ONCOLOGY | SUBTYPES | RESISTANCE | COMBINATION | CANCER | EXPRESSION
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 12/2017, Volume 28, Issue 12, pp. 3092 - 3097
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 01/2020, Volume 26, Issue 1, pp. 135 - 146
Identification of clinically actionable molecular subtypes of pancreatic ductal adenocarcinoma (PDAC) is key to improving patient outcome. Intertumoral... 
MITOCHONDRIAL PYRUVATE CARRIER | METABOLISM | ONCOLOGY | SUBTYPES | PATHWAY | GROWTH | STATIN USE | MUTATIONAL LANDSCAPE | TUMOR | RISK | DEFINES
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 08/2014, Volume 9, Issue 8, pp. 1180 - 1186
Over the past decade, well tolerated second-line therapies for advanced non–small-cell lung cancer have been approved including erlotinib and pemetrexed in... 
Second line | Non–small-cell lung cancer | Erlotinib | Pemetrexed | Docetaxel | Predictors | Non-small-cell lung cancer | GEFITINIB | 1ST-LINE CHEMOTHERAPY | RANDOMIZED-TRIAL | PLUS CARBOPLATIN | MAINTENANCE THERAPY | PHASE-III TRIAL | SUPPORTIVE CARE | CISPLATIN | ONCOLOGY | RESPIRATORY SYSTEM | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Lung Neoplasms - ethnology | Age Factors | Guanine - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Vinblastine - analogs & derivatives | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Retrospective Studies | Drug Therapy - trends | Carcinoma, Non-Small-Cell Lung - pathology | Survival Rate - trends | Deoxycytidine - administration & dosage | Carcinoma, Non-Small-Cell Lung - ethnology | British Columbia | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Factors | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Platinum Compounds - administration & dosage | Asian Continental Ancestry Group - statistics & numerical data | Deoxycytidine - analogs & derivatives | Guanine - administration & dosage
Journal Article